Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plant Extracts | 8 | 2020 | 32 | 3.410 |
Why?
|
| Candida albicans | 10 | 2020 | 15 | 3.270 |
Why?
|
| Antifungal Agents | 10 | 2024 | 40 | 2.770 |
Why?
|
| Sapindaceae | 6 | 2020 | 6 | 2.540 |
Why?
|
| Biofilms | 5 | 2020 | 15 | 2.360 |
Why?
|
| Candida | 6 | 2022 | 24 | 2.020 |
Why?
|
| Anti-Bacterial Agents | 4 | 2019 | 293 | 1.520 |
Why?
|
| Microbial Sensitivity Tests | 10 | 2024 | 198 | 1.370 |
Why?
|
| Hyphae | 3 | 2020 | 3 | 1.370 |
Why?
|
| Candidiasis, Oral | 4 | 2015 | 8 | 1.310 |
Why?
|
| Phytochemicals | 2 | 2016 | 2 | 0.990 |
Why?
|
| Disinfection | 3 | 2021 | 6 | 0.920 |
Why?
|
| Streptococcus mutans | 4 | 2019 | 6 | 0.910 |
Why?
|
| Cell Adhesion | 4 | 2020 | 18 | 0.890 |
Why?
|
| Flavones | 2 | 2019 | 2 | 0.780 |
Why?
|
| Staphylococcus aureus | 2 | 2020 | 43 | 0.720 |
Why?
|
| Microbial Viability | 2 | 2018 | 11 | 0.710 |
Why?
|
| Disinfectants | 1 | 2021 | 3 | 0.690 |
Why?
|
| Listeria monocytogenes | 1 | 2021 | 6 | 0.690 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2020 | 1 | 0.670 |
Why?
|
| Fabaceae | 1 | 2020 | 2 | 0.670 |
Why?
|
| Laboratories, Dental | 1 | 2020 | 1 | 0.660 |
Why?
|
| Ergosterol | 1 | 2020 | 2 | 0.660 |
Why?
|
| Flavonoids | 1 | 2020 | 7 | 0.660 |
Why?
|
| Virulence Factors | 2 | 2016 | 18 | 0.620 |
Why?
|
| Denture Bases | 1 | 2018 | 1 | 0.590 |
Why?
|
| Resins, Synthetic | 1 | 2018 | 3 | 0.590 |
Why?
|
| Plant Leaves | 5 | 2020 | 13 | 0.570 |
Why?
|
| Lythraceae | 1 | 2016 | 1 | 0.510 |
Why?
|
| Periodontal Pocket | 1 | 2016 | 1 | 0.500 |
Why?
|
| Bacteria, Anaerobic | 1 | 2016 | 3 | 0.500 |
Why?
|
| beta-Lactamases | 1 | 2016 | 23 | 0.490 |
Why?
|
| Phospholipases | 2 | 2020 | 3 | 0.480 |
Why?
|
| Humans | 15 | 2024 | 14537 | 0.450 |
Why?
|
| HIV Seropositivity | 2 | 2014 | 265 | 0.440 |
Why?
|
| Neoplasms | 1 | 2015 | 147 | 0.420 |
Why?
|
| Colony Count, Microbial | 5 | 2020 | 14 | 0.410 |
Why?
|
| Candidiasis | 3 | 2024 | 15 | 0.380 |
Why?
|
| Carrier State | 2 | 2014 | 92 | 0.340 |
Why?
|
| Bacteroides Infections | 1 | 2009 | 1 | 0.320 |
Why?
|
| Focal Infection, Dental | 1 | 2009 | 1 | 0.320 |
Why?
|
| Ludwig's Angina | 1 | 2009 | 1 | 0.320 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2008 | 195 | 0.320 |
Why?
|
| Peptide Hydrolases | 1 | 2009 | 3 | 0.310 |
Why?
|
| Staphylococcal Infections | 1 | 2009 | 31 | 0.310 |
Why?
|
| Epithelial Cells | 1 | 2009 | 14 | 0.310 |
Why?
|
| Mouthwashes | 1 | 2008 | 3 | 0.290 |
Why?
|
| Virulence | 3 | 2020 | 25 | 0.270 |
Why?
|
| Adult | 6 | 2016 | 5913 | 0.270 |
Why?
|
| Yeasts | 1 | 2006 | 3 | 0.260 |
Why?
|
| Mycoses | 1 | 2006 | 8 | 0.250 |
Why?
|
| Female | 7 | 2016 | 9103 | 0.230 |
Why?
|
| Histatins | 1 | 2024 | 1 | 0.220 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 23 | 0.220 |
Why?
|
| Apoptosis | 1 | 2024 | 40 | 0.210 |
Why?
|
| HIV Infections | 4 | 2012 | 5097 | 0.200 |
Why?
|
| Middle Aged | 4 | 2016 | 3601 | 0.190 |
Why?
|
| Food Safety | 1 | 2021 | 1 | 0.170 |
Why?
|
| Food Handling | 1 | 2021 | 5 | 0.170 |
Why?
|
| Listeriosis | 1 | 2021 | 8 | 0.170 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2014 | 472 | 0.170 |
Why?
|
| Dental Caries | 2 | 2018 | 10 | 0.170 |
Why?
|
| Tannins | 1 | 2020 | 1 | 0.170 |
Why?
|
| Antioxidants | 1 | 2020 | 26 | 0.170 |
Why?
|
| Denture, Complete | 1 | 2020 | 1 | 0.170 |
Why?
|
| Equipment Contamination | 1 | 2020 | 5 | 0.170 |
Why?
|
| Monoterpenes | 1 | 2020 | 1 | 0.160 |
Why?
|
| Phenols | 1 | 2020 | 4 | 0.160 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2021 | 135 | 0.160 |
Why?
|
| Male | 4 | 2016 | 6754 | 0.150 |
Why?
|
| Drug Carriers | 1 | 2019 | 93 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2019 | 104 | 0.150 |
Why?
|
| Stomatitis, Denture | 1 | 2018 | 1 | 0.150 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2018 | 34 | 0.150 |
Why?
|
| Acids | 1 | 2018 | 1 | 0.150 |
Why?
|
| Triclosan | 2 | 2008 | 2 | 0.140 |
Why?
|
| Chlorhexidine | 2 | 2008 | 10 | 0.140 |
Why?
|
| Animals | 1 | 2021 | 1081 | 0.140 |
Why?
|
| Saliva | 2 | 2008 | 22 | 0.140 |
Why?
|
| Adolescent | 3 | 2009 | 2985 | 0.130 |
Why?
|
| Carboxylic Acids | 1 | 2016 | 3 | 0.130 |
Why?
|
| Chronic Periodontitis | 1 | 2016 | 2 | 0.120 |
Why?
|
| Mouth | 1 | 2016 | 8 | 0.120 |
Why?
|
| beta-Lactam Resistance | 1 | 2016 | 5 | 0.120 |
Why?
|
| Reference Values | 1 | 2016 | 64 | 0.120 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2016 | 35 | 0.120 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 53 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 260 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 468 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2015 | 480 | 0.110 |
Why?
|
| Logistic Models | 2 | 2012 | 254 | 0.100 |
Why?
|
| Young Adult | 2 | 2009 | 2498 | 0.090 |
Why?
|
| Aged | 1 | 2016 | 1740 | 0.090 |
Why?
|
| South Africa | 2 | 2018 | 7596 | 0.080 |
Why?
|
| Bacteroides | 1 | 2009 | 1 | 0.080 |
Why?
|
| Cellulitis | 1 | 2009 | 1 | 0.080 |
Why?
|
| Suppuration | 1 | 2009 | 1 | 0.080 |
Why?
|
| Urea | 1 | 2009 | 3 | 0.080 |
Why?
|
| Mouth Diseases | 1 | 2009 | 3 | 0.080 |
Why?
|
| Mouth Mucosa | 1 | 2009 | 7 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2009 | 96 | 0.080 |
Why?
|
| Risk Factors | 2 | 2012 | 1475 | 0.080 |
Why?
|
| Benzydamine | 1 | 2008 | 1 | 0.070 |
Why?
|
| Sodium Fluoride | 1 | 2008 | 2 | 0.070 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2008 | 16 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2008 | 889 | 0.060 |
Why?
|
| beta-Defensins | 1 | 2024 | 1 | 0.050 |
Why?
|
| alpha-Defensins | 1 | 2024 | 1 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2024 | 3 | 0.050 |
Why?
|
| Cytochromes c | 1 | 2024 | 2 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2024 | 7 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2012 | 1324 | 0.050 |
Why?
|
| Peptides | 1 | 2022 | 40 | 0.050 |
Why?
|
| Eugenol | 1 | 2020 | 2 | 0.040 |
Why?
|
| Thymol | 1 | 2020 | 3 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 11 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 20 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2012 | 133 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 171 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 151 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 146 | 0.020 |
Why?
|
| Tuberculosis | 1 | 2012 | 543 | 0.020 |
Why?
|